NCT04006769View on ClinicalTrials.gov

Entacapone Combination With Imatinib for Treatment of GIST

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 30, 2020

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Gastrointestinal Stromal Tumor, Malignant
Interventions
DRUG

Entacapone

Entacapone tablet

DRUG

Imatinib Mesylate

Imatinib Mesylate tablet

Trial Locations (1)

410008

Bin Li, MD, Changsha

All Listed Sponsors
lead

Xiangya Hospital of Central South University

OTHER

NCT04006769 - Entacapone Combination With Imatinib for Treatment of GIST | Biotech Hunter | Biotech Hunter